Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


US Policy Quick Bits: Point-Of-Care Dx, Bundling, And Chatter On The Hill

Executive Summary

A concise look at key US policy developments and events that unfolded over the past week, including a controversial CLIA waiver draft guidance from FDA and the Trump administration's new direction on bundled payment models.


Related Content

US FDA Chief Favors LDT Approach In Bucshon-DeGette Bill
US FDA Emphasizes Pediatric Consideration In X-Ray Design
US FDA Willing And Ready To Approve Novel Cardiac Troponin Assays
Could CMS Changes To Bundled Pay Models Stifle Medtechs' Value-Based Pay Plans?
21st Century Cures Implementation: Device Provision Updates
Full Steam Ahead On Medtech Value-Based Business Models
Coming Together On CLIA Waivers? Industry Hopes To Recruit Patients, Providers To Push Reform





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts